GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » BioLight Life Sciences Ltd (XTAE:BOLT) » Definitions » EV-to-FCF

BioLight Life Sciences (XTAE:BOLT) EV-to-FCF : -0.68 (As of Apr. 29, 2024)


View and export this data going back to 2005. Start your Free Trial

What is BioLight Life Sciences EV-to-FCF?

EV-to-FCF is calculated as enterprise value divided by its free cash flow. As of today, BioLight Life Sciences's Enterprise Value is ₪7.21 Mil. BioLight Life Sciences's Free Cash Flow for the trailing twelve months (TTM) ended in Dec. 2023 was ₪-10.63 Mil. Therefore, BioLight Life Sciences's EV-to-FCF for today is -0.68.

The historical rank and industry rank for BioLight Life Sciences's EV-to-FCF or its related term are showing as below:

XTAE:BOLT' s EV-to-FCF Range Over the Past 10 Years
Min: -2.54   Med: -0.69   Max: 1.16
Current: -0.68

During the past 12 years, the highest EV-to-FCF of BioLight Life Sciences was 1.16. The lowest was -2.54. And the median was -0.69.

XTAE:BOLT's EV-to-FCF is ranked worse than
100% of 394 companies
in the Biotechnology industry
Industry Median: 4.23 vs XTAE:BOLT: -0.68

EV-to-FCF is a valuation multiple that allows analysts and investors to compare stocks, preferably in the same sector or industry. This important multiple is often used in conjunction with, or as an alternative to, the PE Ratio to determine the fair market value of a company.

As of today (2024-04-29), BioLight Life Sciences's stock price is ₪3.384. BioLight Life Sciences's Earnings per Share (Diluted) for the trailing twelve months (TTM) ended in Dec. 2023 was ₪-5.600. Therefore, BioLight Life Sciences's PE Ratio for today is At Loss.


BioLight Life Sciences EV-to-FCF Historical Data

The historical data trend for BioLight Life Sciences's EV-to-FCF can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

BioLight Life Sciences EV-to-FCF Chart

BioLight Life Sciences Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
EV-to-FCF
Get a 7-Day Free Trial Premium Member Only Premium Member Only -0.15 1.03 -1.85 -1.43 -1.52

BioLight Life Sciences Semi-Annual Data
Jun14 Dec14 Jun15 Dec15 Jun16 Dec16 Jun17 Dec17 Jun18 Dec18 Jun19 Dec19 Jun20 Dec20 Jun21 Dec21 Jun22 Dec22 Jun23 Dec23
EV-to-FCF Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only -1.85 -4.02 -1.43 - -1.52

Competitive Comparison of BioLight Life Sciences's EV-to-FCF

For the Biotechnology subindustry, BioLight Life Sciences's EV-to-FCF, along with its competitors' market caps and EV-to-FCF data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


BioLight Life Sciences's EV-to-FCF Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, BioLight Life Sciences's EV-to-FCF distribution charts can be found below:

* The bar in red indicates where BioLight Life Sciences's EV-to-FCF falls into.



BioLight Life Sciences EV-to-FCF Calculation

BioLight Life Sciences's EV-to-FCF for today is calculated as:

EV-to-FCF=Enterprise Value (Today)/Free Cash Flow (TTM)
=7.210/-10.63
=-0.68

BioLight Life Sciences's current Enterprise Value is ₪7.21 Mil.
For company reported semi-annually, GuruFocus uses latest annual data as the TTM data. BioLight Life Sciences's Free Cash Flow for the trailing twelve months (TTM) ended in Dec. 2023 was ₪-10.63 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


BioLight Life Sciences  (XTAE:BOLT) EV-to-FCF Explanation

EV-to-FCF is a valuation multiple that allows analysts and investors to compare stocks, preferably in the same sector or industry. This important multiple is often used in conjunction with, or as an alternative to, the PE Ratio to determine the fair market value of a company.

BioLight Life Sciences's PE Ratio for today is calculated as:

PE Ratio=Share Price (Today)/Earnings per Share (Diluted) (TTM)
=3.384/-5.600
=At Loss

BioLight Life Sciences's share price for today is ₪3.384.
For company reported semi-annually, GuruFocus uses latest annual data as the TTM data. BioLight Life Sciences's Earnings per Share (Diluted) for the trailing twelve months (TTM) ended in Dec. 2023 was ₪-5.600.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Enterprise Value is used because it is a more complete measure in reflecting how much an investor pays when buying a company. Free Cash Flow is an important financial metric because it represents the actual amount of cash at a company's disposal. Companies with a low EV-to-FCF ratio, combined with a strong balance sheet are generally considered as undervalued.


BioLight Life Sciences EV-to-FCF Related Terms

Thank you for viewing the detailed overview of BioLight Life Sciences's EV-to-FCF provided by GuruFocus.com. Please click on the following links to see related term pages.


BioLight Life Sciences (XTAE:BOLT) Business Description

Traded in Other Exchanges
N/A
Address
Kiryat Atidim, Building 7, Entrance 1, 2nd Floor, Tel-Aviv, ISR, 6158101
BioLight Life Sciences Ltd is an emerging global ophthalmic company. It is engaged in the discovery, development, and commercialization of products and product candidates which address ophthalmic conditions, including glaucoma, dry eye syndrome and age-related macular degeneration. The firm's products include ioptimate, eye-d technology, and diagnostear. The company has the Eye cluster and the Cancer diagnostics cluster operating segments. It derives the majority of its revenues from the Eye cluster segment.

BioLight Life Sciences (XTAE:BOLT) Headlines

From GuruFocus